Development and validity assessment of ELISA test with recombinant chimeric protein of SARS-CoV-2

Serological tests developed for COVID-19 diagnostic are based on antibodies specific for SARS-CoV-2 antigens. Most of the antigens consist of a fragment or a whole amino acid sequence of the nucleocapsid or spike proteins. We evaluated a chimeric recombinant protein as an antigen in an ELISA test, u...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandez, Zoraida, de Arruda Rodrigues, Rudielle, Torres, Jaire Marinho, Marcon, Gláucia Elisete Barbosa, de Castro Ferreira, Eduardo, de Souza, Vanessa Felipe, Sarti, Elaine Fernandes Baez, Bertolli, Guilherme Ferminao, Araujo, Daniel, Demarchi, Luiz Henrique Ferraz, Lichs, Gislene, Zardin, Marina Umaki, Gonçalves, Crhistinne Cavalheiro Maymone, Cuenca, Valter, Favacho, Alexsandra, Guilhermino, Jislaine, dos Santos, Lenita Ramires, de Araujo, Flábio Ribeiro, Silva, Marcio Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174469/
https://www.ncbi.nlm.nih.gov/pubmed/37179011
http://dx.doi.org/10.1016/j.jim.2023.113489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174469/
https://www.ncbi.nlm.nih.gov/pubmed/37179011
http://dx.doi.org/10.1016/j.jim.2023.113489

Ejemplares similares